||March

Le Point : Disease of the retina: progress in view

Scientific research and high technology now allow the blind and partially sighted to recover some of their lost sense.In the spotlight. Artificial implants, gene therapy, stem cells, eye transplantation, brain stimulation ... Researchers are making great strides towards light. Read more »

2019-09-11T17:30:03+02:00March 23rd, 2019|News|

Dry AMD: “the results of our implant exceed our expectations”

In September 2018, 5 patients with advanced atrophic dry AMD received the new generation PRIMA subretinal implant. Six months later, all had preserved their peripheral vision, and all are able to perceive light signals from central area. Read more »

2019-09-11T17:30:04+02:00March 11th, 2019|News|

#LetsGoFrance : 19 finalists, 19 talents who will keep France moving in 2019 !

There were 445 entries in the #LetsgoFrance competition, then 64 semi-finalists. Thanks to the votes of PwC's 5,000 employees, they are now only 19! Revealed this week in Forbes magazine, the 19 finalists of the #LetsgoFrance Trophies are now preparing for the pitch before the Grand Jury. Read more »

2019-09-11T17:30:03+02:00March 7th, 2019|News|

19TH CONGRESS EURETINA : 5 – 8 SEPT 2019 Paris, France

The 19th congress of European Retina, Macula and Vitreous Society (EURETINA) will take place from 5 - 8 Sept at at the Palais des Congrès in Paris, France. The congress touches on fields like Retina, Eyesight, Medical, Healthcare and Ophthalmology. The Annual Congress programme will have a clinical focus and include topics such as AMD,

2019-09-11T17:30:05+02:00March 1st, 2019|Events|

HealthTech Investor Day® by France Biotech – 24 et 25 June 2019, Paris

Welcome to the HealthTech Investor Day® by FranceBiotech,under the High Patronage of Mr Emmanuel MACRON President of the French Republic.For the first time, France Biotech(The French Association of French HealthTech Entrepreneurs) is organizing a one-on-one meetings event to connect leading international investors, pharmaceutical companies and European top management innovative companies in HealthTech. Read more »

2019-09-11T17:30:03+02:00March 1st, 2019|Events|

3rd International MaculArt Meeting 23-25 June 2019, Paris, France

Why MaculArt? Because of the beauty of macular imaging, because of our daily enthusiasm for management of macular disorders, because our field is in permanent renewal and full of innovations, the field of medical macula can be considered as an Art.Ophthalmologists from around the globe will be present to share their knowledge and discuss major

2019-09-11T17:30:05+02:00March 1st, 2019|Events|